Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 4749 of 5804
-
Whey protein boosts teen soccer stars?
Symptom relief CompletedThe overall aim of this project is to compare protein supplementation on performance, recovery, and body composition changes in adolescent soccer players between the whey protein and the control group in response to the 10-12-week intervention.
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Sculptra safety checked beyond the face
Symptom relief CompletedMulti-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas
Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Scientists track rare genetic hearing loss over time
Knowledge-focused Recruiting nowThis is a retrospective and prospective longitudinal study in participants with Otoferlin Gene-Mediated Hearing Loss.
Sponsor: Akouos, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Estrogen cream studied for Post-Birth injury recovery
Symptom relief TerminatedObstetric anal sphincter injuries (OASIS) cause significant morbidity and are well known risk factors for sexual dysfunction, urinary and anal incontinence. Postpartum and breastfeeding are relative hypoestrogenic states with risk factors for dyspareunia and vaginal atrophy. Estr…
Phase: PHASE4 • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New study tests heat treatment for painful uterine condition
Knowledge-focused CompletedTo observe the effects of radiofrequency ablation on adenomyosis through the pathological analysis of treated tissue that has been removed during planned hysterectomy.
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New test could predict dangerous blood pressure drops in dialysis patients
Diagnosis CompletedHemodynamic instability episodes are a frequent complication of renal replacement therapies in critically ill patients, and their incidence is associated with worse survival. Hypovolemia, identified by the existence of biventricular preload dependence, is responsible for one epis…
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 27, 2026 09:05 UTC
-
Experimental eye drug targets genetic blindness
Disease control CompletedAn open-label Phase II clinical trial, 8 (eight) subjects with retinitis pigmentosa due to rhodopsin mutations (including P23H) will be identified and treated with serial intravitreal injections of ADX-2191 in the worse seeing eye. Ocular structure and function will be evaluated.
Phase: PHASE2 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New italian registry aims to unlock secrets of rare heart disease
Knowledge-focused Recruiting nowThe study aims, by generating a large registry of patients with ATTR amyloidosis, including data at diagnosis and during follow up, to describe the natural history of ATTR amyloidosis in a real-world setting and to define and validate prognostic models, response criteria applicab…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New study aims to predict spinal cord disease progression
Knowledge-focused Recruiting nowTo create a research repository of patients with known degenerative cervical myelopathy (DCM) and a control cohort of subjects who have non-myelopathic spinal disease. This repository will be used to assess functional and/or biological measures that may allow for improved predict…
Sponsor: Francis Farhadi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Silver dressing passes safety check for wound care
Disease control CompletedPost Market Surveillance Study to confirm the safety and performance of Silver II Non-Woven Dressing in Chronic and Acute Wounds
Phase: NA • Sponsor: Advanced Medical Solutions Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Lung cancer study aims to unlock genetic secrets
Knowledge-focused Recruiting nowThe study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first a…
Sponsor: Tempus AI • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
France pilots collaborative mental health model in primary care
Knowledge-focused CompletedFrequent mental disorders (anxiety or mood disorders), an important part of primary care patient care, remain insufficiently detected and treated. Improving their care requires better coordination between general practice and specialized care. The collaborative care model develop…
Phase: NA • Sponsor: Dr Nadia YOUNES • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Can a Growth-Hormone blocker stay safe in everyday use? a korean study investigates
Knowledge-focused CompletedNon-interventional observational study, to identify safety and effectiveness of Somavert during the post-marketing period based on the Korean RMP as required by the regulations of Ministry of Food and Drug Safety (MFDS)
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
New biologic LP-003 takes first step in human safety trial
Knowledge-focused CompletedThe purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-003 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP…
Phase: PHASE1 • Sponsor: Longbio Pharma • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Your job and home may predict spinal infection comeback
Knowledge-focused Recruiting nowThis is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study al…
Sponsor: Francis Farhadi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
New psoriasis pill shows early promise in small safety trial
Symptom relief CompletedThis is a parallel, Phase 1, single center, 2-arm, double-blind, randomized, placebo-controlled with a ratio 2 active: 1 placebo study for treatment of mild to moderate psoriasis participants. Approximately 36 participants (24 in the SAR441566 group and 12 in the placebo group) a…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New biologic AZD7798 tested in early Crohn's trial
Disease control CompletedThis study will assess the safety, tolerability, immunogenicity, and pharmacokinetics (PK), and explore the pharmacodynamics (PD) following single ascending dose administration and repeat dose administration in healthy subjects and patients with Crohn's disease.
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Genetic clues could sharpen lymphoma diagnosis
Knowledge-focused CompletedThis is a retrospective analysis of the presence of chromosomal rearrangements involving MYC, BCL2 and BCL6 genes by FISH in a retrospective, single-center series of large B-cell lymphomas, in order to allow a better classifications of these cases according to the current WHO 201…
Sponsor: Andrés José Maria Ferreri • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:02 UTC
-
Protein power: new study probes link between diet and heart risk
Knowledge-focused OngoingHigh protein low carbohydrate diets have become popular in recent years to help facilitate weight loss. It is controversial if these diets are associated with an increased risk of cardiovascular disease. Recent work in mice has implicated monocytes/macrophages and mTOR signaling …
Phase: NA • Sponsor: University of Missouri-Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Promising seizure drug study halted early
Disease control TerminatedExtension study to evaluate how safe and tolerable the drug NBI-921352 is when used as adjunctive therapy in participants with SCN8A developmental and epileptic encephalopathy syndrome (SCN8A-DEE).
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC